New York Life Investment Management’s Coca-Cola Europacific Partners CCEP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-3,956
Closed -$358K 786
2025
Q3
$358K Buy
3,956
+79
+2% +$7.33K ﹤0.01% 791
2025
Q2
$359K Sell
3,877
-179
-4% -$16K ﹤0.01% 784
2025
Q1
$353K Sell
4,056
-489
-11% -$39.9K ﹤0.01% 801
2024
Q4
$349K Buy
4,545
+1,015
+29% +$78.4K ﹤0.01% 795
2024
Q3
$278K Sell
3,530
-131
-4% -$10K ﹤0.01% 834
2024
Q2
$267K Buy
3,661
+21
+0.6% +$1.51K ﹤0.01% 827
2024
Q1
$255K Sell
3,640
-456
-11% -$31.3K ﹤0.01% 1311
2023
Q4
$273K Buy
4,096
+158
+4% +$9.66K ﹤0.01% 1249
2023
Q3
$246K Buy
3,938
+9
+0.2% +$572 ﹤0.01% 1242
2023
Q2
$253K Buy
+3,929
New +$249K ﹤0.01% 1271

Other funds holding CCEP

New York Life Investment Management's CCEP Position: Q4 2025 in Review

New York Life Investment Management sold out of Coca-Cola Europacific Partners (CCEP) in Q4 2025, closing a stake of 3,956 shares — an estimated $358K sold.

New York Life Investment Management first reported a position in CCEP in Q2 2023 and held it in 10 quarters. The position peaked at $359K in Q2 2025. 567 funds tracked by Wall St. Rank hold CCEP as of Q4 2025.

  • New York Life Investment Management reported no remaining Coca-Cola Europacific Partners position as of Q4 2025 after selling out during the quarter.
  • New York Life Investment Management sold 3,956 Coca-Cola Europacific Partners shares in Q4 2025, an estimated $358K.
  • New York Life Investment Management first reported a position in Coca-Cola Europacific Partners in Q2 2023 and held it in 10 quarters.
  • New York Life Investment Management's Coca-Cola Europacific Partners position peaked at $359K in Q2 2025.
  • 567 funds tracked by Wall St. Rank held Coca-Cola Europacific Partners as of Q4 2025.

Based on New York Life Investment Management's 13F filing for Q4 2025, filed 5 Feb 2026.